AVITA Medical annual depreciation and amortization
2018
2019
2020
2021
2021
2022
2023
2024
2025
AVITA Medical Depreciation & Amortization Growth & History (RCEL)
AVITA Medical's depreciation and amortization was $2.3M for fiscal 2025.
View full AVITA Medical company overviewAVITA Medical annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.3M | $1.2M | +108.44% |
| 2024 | 2024-12-31 | $1.1M | $494,000 | +78.16% |
| 2023 | 2023-12-31 | $632,000 | $64,000 | +11.27% |
| 2022 | 2022-12-31 | $568,000 | $238,000 | +72.12% |
| 2021 · Dec 31 | 2021-12-31 | $330,000 | — | — |
| 2021 · Jun 30 | 2021-06-30 | $715,000 | $250,000 | +53.76% |
| 2020 | 2020-06-30 | $465,000 | $196,000 | +72.86% |
| 2019 | 2019-06-30 | $269,000 | $159,000 | +144.55% |
| 2018 | 2018-06-30 | $110,000 | — | — |
AVITA Medical quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $605,000 | $53,000 | +9.60% |
| Q1 2026 | 2026-03-31 | $627,000 | $106,000 | +20.35% |
| Q4 2025 | 2025-12-31 | $700,000 | — | — |
| Q3 2025 | 2025-09-30 | $574,000 | $264,000 | +85.16% |
| Q2 2025 | 2025-06-30 | $552,000 | $348,000 | +170.59% |
| Q1 2025 | 2025-03-31 | $521,000 | $318,000 | +156.65% |
| Q3 2024 | 2024-09-30 | $310,000 | $146,000 | +89.02% |
| Q2 2024 | 2024-06-30 | $204,000 | $58,000 | +39.73% |
| Q1 2024 | 2024-03-31 | $203,000 | $68,000 | +50.37% |
| Q3 2023 | 2023-09-30 | $164,000 | $26,000 | +18.84% |
| Q2 2023 | 2023-06-30 | $146,000 | $9,000 | +6.57% |
| Q1 2023 | 2023-03-31 | $135,000 | −$28,000 | −17.18% |
| Q3 2022 | 2022-09-30 | $138,000 | −$36,000 | −20.69% |
| Q2 2022 | 2022-06-30 | $137,000 | −$39,000 | −22.16% |
| Q1 2022 · Mar 31 | 2022-03-31 | $163,000 | −$4,000 | −2.40% |
| Q1 2022 · Sep 30 | 2021-09-30 | $174,000 | −$37,000 | −17.54% |
| Q4 2021 | 2021-06-30 | $176,000 | — | — |
| Q3 2021 | 2021-03-31 | $167,000 | $76,000 | +83.52% |
| Q2 2021 | 2020-12-31 | $162,000 | $64,000 | +65.31% |
| Q1 2021 | 2020-09-30 | $211,000 | $145,000 | +219.70% |
| Q3 2020 | 2020-03-31 | $91,000 | — | — |
| Q2 2020 | 2019-12-31 | $98,000 | — | — |
| Q1 2020 | 2019-09-30 | $66,000 | — | — |
AVITA Medical depreciation and amortization trends
Between the periods ended 2018-06-30 and 2025-12-31, AVITA Medical's depreciation and amortization increased from $110,000 to $2.3M, a change of $2.2M. The latest reported quarter, Q2 2026, shows $605,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AVITA Medical source filings ↗